AURKB and neoplasm: Furthermore, the expression levels of aurora A (Figure 5D), aurora B (Figure 5E), γH2AX (Figure 5F), phospho-ERK (Figure 5G), and ROS marker malondialdehyde (MDA; Figure 5H) in xenograft tumor sections were increased after CYT-Rx20 treatment.